IVY PARAYO: Open Payments
NPI 1386111532 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,741 in 128 payments from 15 companies in 2025. Trend: 2023 $3,340 · 2024 $3,022 · 2025 $2,741
Food & beverage: $2,569Education: $172
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $783 |
| Janssen Biotech, Inc. | 32 | $669 |
| Novartis Pharmaceuticals Corporation | 13 | $291 |
| GENZYME CORPORATION | 6 | $219 |
| UCB, Inc. | 10 | $176 |
| LEO Pharma Inc. | 7 | $137 |
| Galderma Laboratories, L.P. | 6 | $104 |
| Regeneron Healthcare Solutions, Inc. | 2 | $77 |
| Lilly USA, LLC | 4 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, COSENTYX, Bimzelx, NEMLUVIO, ADBRY.
Industry payments across AK — which companies pay providers there.
